Schedule 13D ownership disclosure

MARINUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 56854Q101

Event date: 2014-08-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,476,886
Percent of class
18.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000904454-14-000580
Form type
SC 13D
Filer
Domain Partners VI, L.P.
CIK
CIK 1298033
Filed
Aug 15, 2014
Reporting period
Aug 05, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub